Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02812771 · ClinicalTrials.gov registry record · Phase 4
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Phase 4 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT02812771 is a Phase 4 study that has completed, run by Bausch Health Americas. The registered enrollment target is 62 participants.
The verdict
NCT02812771, a Phase 4 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
Safety and Pharmacokinetics (PK) of a once daily topical application of efinaconazole in the treatment of pediatric subjects with mild to severe onychomycosis of the toenails.
Interventions
- DRUG Efinaconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2016-08-04 |
| Est. Completion | 2019-01-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02812771
The ClinicalTrials.gov registry entry for NCT02812771 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Efinaconazole is the first listed.
NCT02812771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02812771 about?
NCT02812771 is a clinical study titled "Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis". Safety and Pharmacokinetics (PK) of a once daily topical application of efinaconazole in the treatment of pediatric subjects with mild to severe onychomycosis of the toenails.
What is the current status of trial NCT02812771?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2016-08-04. Estimated completion is 2019-01-14.
What interventions are being tested in trial NCT02812771?
The interventions under investigation include: Efinaconazole (DRUG).
Who is sponsoring clinical trial NCT02812771?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.